litlas
Log inCreate account

Andreas Wollenberg

Active 1992–2025

179
Papers
25,171
Citations
81
h-index
169
i10-index

Citations

Citations per year for Andreas Wollenberg1993: 7 citations1994: 13 citations1995: 7 citations1996: 10 citations1997: 11 citations1998: 14 citations1999: 18 citations2000: 26 citations2001: 35 citations2002: 30 citations2003: 63 citations2004: 62 citations2005: 73 citations2006: 58 citations2007: 47 citations2008: 94 citations2009: 70 citations2010: 70 citations2011: 48 citations2012: 82 citations2013: 108 citations2014: 90 citations2015: 74 citations2016: 111 citations2017: 180 citations2018: 234 citations2019: 854 citations2020: 1,049 citations2021: 1,231 citations2022: 943 citations2023: 958 citations2024: 1,398 citations2025: 806 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,771 citing papers, 19.6% of this breakdownGermany: 877 citing papers, 9.7% of this breakdownUnited Kingdom: 562 citing papers, 6.2% of this breakdownItaly: 488 citing papers, 5.4% of this breakdownFrance: 442 citing papers, 4.9% of this breakdownJapan: 442 citing papers, 4.9% of this breakdownChina: 416 citing papers, 4.6% of this breakdownCanada: 345 citing papers, 3.8% of this breakdownSwitzerland: 310 citing papers, 3.4% of this breakdownNetherlands: 300 citing papers, 3.3% of this breakdownDenmark: 269 citing papers, 3% of this breakdownSpain: 258 citing papers, 2.8% of this breakdown
0%19.6%Other 28.4%

Institutions

Fields

  • Medicine78.5%
  • Immunology and Microbiology11.6%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.6%
  • Agricultural and Biological Sciences0.4%
  • Other1.5%

Topics

  • Dermatology and Skin Diseases22.4%
  • Allergic Rhinitis and Sensitization10.7%
  • Asthma and respiratory diseases8.1%
  • Psoriasis: Treatment and Pathogenesis7.1%
  • Food Allergy and Anaphylaxis Research4.2%
  • Urticaria and Related Conditions4%
  • Other43.5%

Coauthors

All papers

Open in search
  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Authors: Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu - New England Journal of Medicine 2016 cited by 2,045

  2. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    Authors: Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky, Margitta Worm, Charles Lynde, J.‐P. Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Yves Poulin, Aleksandra Lesiak, Leon Kircik, S.H. Cho, Pedro Herranz, Michael J. Cork, Ketty Peris, Louise Abildgaard Steffensen, B K Bang, Alexandra Kuznetsova, T.N. Jensen, Marie Louise Østerdal, Eric L. Simpson, the ECZTRA 1 and ECZTRA 2 study investigators - British Journal of Dermatology 2020 cited by 595

  3. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

    Authors: Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, N. Aszodi, G. Avila Valle, S. Barbarot, Thomas Bieber, Helen A. Brough, Piergiacomo Calzavara‐Pinton, Stéphanie Christen-Zäch, Mette Deleuran, Martin Dittmann, Corinna Dressler, A. Fink‐Wagner, Nicole Fosse, Krisztián Gáspár, Louise A. A. Gerbens, Uwe Gieler, Giampiero Girolomoni, Stamatios Gregoriou, Charlotte G. Mørtz, Alexander Nast, Uffe Nygaard, M. Redding, Eva Maria Rehbinder, Johannes Ring, Mariateresa Rossi, E. Serra‐Baldrich, Dagmar Simon, Zsuzsanna Szalai, Jacek C. Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr - Journal of the European Academy of Dermatology and Venereology 2022 cited by 406

  4. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

    Authors: Andreas Wollenberg, S. Barbarot, Thomas Bieber, Stéphanie Christen‐Zaech, Mette Deleuran, A. Fink‐Wagner, Uwe Gieler, Giampiero Girolomoni, S. Lau, Antonella Muraro, Magdalena Czarnecka‐Operacz, T. Schäfer, Peter Schmid‐Grendelmeier, Dagmar Simon, Zsuzsanna Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Antonio Torrelo, Thomas Werfel, Johannes Ring - Journal of the European Academy of Dermatology and Venereology 2018 cited by 1,175

  5. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Weily Soong, Mercedes E. González, Lynda C. Schneider, Robert Sidbury, Benjamin Lockshin, Steven M Meltzer, Zhixiao Wang, Leda Mannent, Nikhil Amin, Yiping Sun, Elizabeth Laws, Bolanle Akinlade, Myles Dillon, Matthew P. Kosloski, Mohamed Kamal, Ariane Dubost-Brama, Naimish Patel, David M. Weinreich, George D. Yancopoulos, John T. O’Malley, Ashish Bansal, A. Pepper, Amy S. Paller, Benjamin Lockshin, David J. Cohen, David M. Pariser, Elaine C. Siegfried, Eric L. Simpson, Jeffrey Leflein, Jeffrey S. Weinberg, John Browning, Joyce Teng, Lara Wine Lee, Lawrence Sher, Lucia Z. Diaz, Lynda C. Schneider, Mercedes E. González, Ned T. Rupp, Peck Y. Ong, Robert Cartwright, Robert Sidbury, Weily Soong, Andreas Pinter, Andreas Wollenberg, Christina Schnopp, Michael J. Cork, Peter D. Arkwright, Anna Korkosz, Dorota Bystrzanowska, Ewa Sygula, Jacek Zdybski, Kamila Padlewska - The Lancet 2022 cited by 264

  6. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

    Authors: Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, C. Paul, Jacob P. Thyssen, Marjolein de Bruin‐Weller, Christian Vestergaard, Julien Sénéschal, Thomas Werfel, Michael J. Cork, B Kunz, Regina Fölster‐Holst, Magdalena Trzeciak, Ulf Darsow, Zsuzsanna Szalai, Mette Deleuran, Laura von Kobyletzki, S. Barbarot, Annice Heratizadeh, Uwe Gieler, DirkJan Hijnen, Stephan Weidinger, L. De Raeve, Åke Svensson, Dagmar Simon, J.‐F. Stalder, Johannes Ring, for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force - Journal of the European Academy of Dermatology and Venereology 2020 cited by 465

  7. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

    Authors: Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Peter D. Arkwright, Melinda Gooderham, Lisa A. Beck, Mark Boguniewicz, Lawrence Sher, Jamie Weisman, John T. O’Malley, Naimish Patel, Megan Hardin, Neil M.H. Graham, Marcella Ruddy, Xian Sun, John D. Davis, Mohamed Kamal, Faisal A. Khokhar, David M. Weinreich, George D. Yancopoulos, Bethany Beazley, Ashish Bansal, Brad Shumel - Journal of the American Academy of Dermatology 2020 cited by 389

  8. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    Authors: Eric L. Simpson, Rodney Sinclair, Seth Forman, Andreas Wollenberg, Roland Aschoff, Michael J. Cork, Thomas Bieber, Jacob P. Thyssen, Gil Yosipovitch, Carsten Flohr, Nina Magnolo, Catherine Maari, Claire Feeney, Pinaki Biswas, Svitlana Tatulych, Hernán Valdez, Ricardo Rojo - The Lancet 2020 cited by 491

  9. European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations

    Authors: Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, N. Aszodi, G. Avila Valle, S. Barbarot, Thomas Bieber, Helen A. Brough, Piergiacomo Calzavara‐Pinton, Stéphanie Christen-Zäch, Mette Deleuran, Martin Dittmann, Corinna Dressler, A. Fink‐Wagner, Nicole Fosse, Krisztián Gáspár, Louise A. A. Gerbens, Uwe Gieler, Giampiero Girolomoni, Stamatios Gregoriou, Charlotte G. Mørtz, Alexander Nast, Uffe Nygaard, M. Redding, Eva Maria Rehbinder, Johannes Ring, Mariateresa Rossi, E. Serra‐Baldrich, Dagmar Simon, Zsuzsanna Szalai, Jacek C. Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr - Journal of the European Academy of Dermatology and Venereology 2022 cited by 266

  10. Conjunctivitis in dupilumab clinical trials

    Authors: Bolanle Akinlade, Emma Guttman‐Yassky, Marjolein de Bruin‐Weller, Eric L. Simpson, Andrew Blauvelt, Michael J. Cork, Errol P. Prens, Penny A. Asbell, Esen K. Akpek, Jonathan Corren, Claus Bachert, Ikuo Hirano, Jonathan Weyne, Andrew Korotzer, Z. Chen, Thomas Hultsch, Xiaoping Zhu, John D. Davis, Leda Mannent, Jennifer D. Hamilton, Ariel Teper, Heribert Staudinger, E. Rizova, Gianluca Pirozzi, Neil M.H. Graham, Brad Shumel, Marius Ardeleanu, Andreas Wollenberg - British Journal of Dermatology 2019 cited by 422

  11. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

    Authors: Amy S. Paller, Carsten Flohr, Michael J. Cork, Anthony Bewley, Andrew Blauvelt, Hwanhee Hong, Shinichi Imafuku, Marie L. A. Schuttelaar, Eric L. Simpson, Weily Soong, Petra Arlert, Katja Wendicke Lophaven, Azra Kurbasic, Lise Soldbro, Natacha Strange Vest, Andreas Wollenberg - JAMA Dermatology 2023 cited by 137

  12. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

    Authors: Thomas Werfel, Jean‐Pierre Allam, Tilo Biedermann, Kilian Eyerich, Stefanie Gilles, Emma Guttman‐Yassky, Wolfram Hoetzenecker, Edward F. Knol, Hans‐Uwe Simon, Andreas Wollenberg, Thomas Bieber, Roger Lauener, Peter Schmid‐Grendelmeier, Claudia Traidl‐Hoffmann, Cezmi A. Akdiş - Journal of Allergy and Clinical Immunology 2016 cited by 589

  13. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

    Authors: Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg, Stephan Weidinger, April W. Armstrong, Jennifer Soung, Silvia Mariel Ferrucci, Renata Gontijo Lima, Michael M. Witte, Wen Xu, Hany Elmaraghy, Chitra R Natalie, Evangeline Pierce, Andrew Blauvelt, ADhere Investigators, Abel Jarell, Neil S. Sadick, Howard Sofen, Paul W Wallace, Jose M Carpio, David Greenstein, Angela Moore, Jose M Mendez, Scott Guenthner, Wendy McFalda, Vivian Laquer, Seth Forman, Todd Schlesinger, Andrew Blauvelt, Jeffrey Crowley, Ricardo Tan, Francis J Averill, Rosalyn Elizabeth George, Eddie Armas, Benjamin Lockshin, Jennifer Soung, Walter K. Nahm, Alison Ehrlich, Sunil Dhawan, Eric L. Simpson, Steve Sitar, Jerry Bagel, Phoebe Rich, Bruce Torkan, David F Fivenson, Jamie Weisman, Melody Lynn Stone, April W. Armstrong, Mirwais Saifi, Brad Glick, Melinda Gooderham, Isaiah Day, Lorne Albrecht, Marni Wiseman, David Gratton, Chi-ho Hong, Bernadetta Majorek‐Olechowska, Adam Reich, Beata Kręcisz, Irena Walecka-Herniczek, Jolanta Węgłowska, Beata Bergler‐Czop, Boguslawa Cimoszko, Kamila Padlewska, Maria Czubek, Andreas Pinter, Kristian Reich, Thomas Wildfeuer, Roland Aschoff - JAMA Dermatology 2023 cited by 143

  14. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

    Authors: Andreas Wollenberg, S. Barbarot, Thomas Bieber, Stéphanie Christen‐Zaech, Mette Deleuran, A. Fink‐Wagner, Uwe Gieler, Giampiero Girolomoni, S. Lau, Antonella Muraro, Magdalena Czarnecka‐Operacz, T. Schäfer, Peter Schmid‐Grendelmeier, Dagmar Simon, Zsuzsanna Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Antonio Torrelo, Thomas Werfel, Johannes Ring - Journal of the European Academy of Dermatology and Venereology 2018 cited by 687

  15. Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

    Authors: Andreas Wollenberg, Michael Howell, Emma Guttman‐Yassky, Jonathan I. Silverberg, Christopher Kell, Koustubh Ranade, Rachel Moate, René van der Merwe - Journal of Allergy and Clinical Immunology 2018 cited by 421

  16. Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

    Authors: Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue, Grażyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida, Jonathan Stewart, Kenji Kabashima - New England Journal of Medicine 2017 cited by 587

  17. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

    Authors: Eric L. Simpson, J.‐P. Lacour, Lynda Spelman, Ricardo Galimberti, Lawrence F. Eichenfield, Robert Bissonnette, Brett King, Jacob P. Thyssen, Jonathan I. Silverberg, Thomas Bieber, Kenji Kabashima, Yuichiro Tsunemi, Antonio Costanzo, Emma Guttman‐Yassky, Lisa A. Beck, Jonathan Janes, Amy M. DeLozier, Margaret Gamalo, Dennis Brinker, T. Cardillo, Fabio P. Nunes, Amy S. Paller, Andreas Wollenberg, Kristian Reich - British Journal of Dermatology 2020 cited by 379

  18. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

    Authors: Sonja Ständer, Gil Yosipovitch, Franz J. Legat, J.‐P. Lacour, C. Paul, Joanna Narbutt, Thomas Bieber, L. Misery, Andreas Wollenberg, Adam Reich, Faiz Ahmad, Christophe Piketty - New England Journal of Medicine 2020 cited by 277

  19. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

    Authors: Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka, Yves Poulin, Jean‐David Bouaziz, Andreas Wollenberg, Dédée F. Murrell, Andrew Alexis, Lisa Lindsey, Faiz Ahmad, Christophe Piketty, Alan Clucas - Journal of Allergy and Clinical Immunology 2019 cited by 271

  20. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

    Authors: Helen Alexander, Amy S. Paller, Claudia Traidl‐Hoffmann, Lisa A. Beck, Anna De Benedetto, Sandipan Dhar, Giampiero Girolomoni, Alan D. Irvine, Phyllis I. Spuls, John Su, Jacob P. Thyssen, Christian Vestergaard, Thomas Werfel, Andreas Wollenberg, Mette Deleuran, Carsten Flohr - British Journal of Dermatology 2019 cited by 214

  21. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

    Authors: Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg, Kristian Reich, Richard B. Warren, D. Staumont‐Sallé, Giampiero Girolomoni, Kim Papp, Marjolein de Bruin‐Weller, Jacob P. Thyssen, Rebecca Zachariae, C.K. Olsen, Andreas Wollenberg - British Journal of Dermatology 2022 cited by 74

  22. Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

    Authors: Andrew Blauvelt, Richard G. Langley, J.‐P. Lacour, Darryl Toth, Vivian Laquer, Stefan Beissert, Andreas Wollenberg, Pedro Herranz, Andrew Pink, Ketty Peris, Stine Fangel, Le Gjerum, Joshua Corriveau, Hidehisa Saeki, Richard B. Warren, Eric L. Simpson, Kristian Reich - Journal of the American Academy of Dermatology 2022 cited by 75

  23. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo

    Authors: Manuel P. Pereira, S. Steinke, Claudia Zeidler, Caroline Forner, Claudia Riepe, Matthias Augustin, S. Bobko, Florence Dalgard, Jesper Elberling, Simone Garcovich, Uwe Gieler, Margarida Gonçalo, Jon Anders Halvorsen, T.A. Leslie, Martin Metz, Adam Reich, Ekin Şavk, Gudrun Schneider, E. Serra‐Baldrich, Hartmut Ständer, Markus Streit, Joanna Wallengren, Karsten Weller, Andreas Wollenberg, Philipp Bruland, Iñaki Soto‐Rey, Michael Storck, Martin Dugas, Elke Weißhaar, Jacek C. Szepietowski, Franz J. Legat, Sonja Ständer, EADV Task Force Pruritus group members - Journal of the European Academy of Dermatology and Venereology 2017 cited by 265

  24. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

    Authors: Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J. Legat, Kim Papp, Linda Stein Gold, Jean‐David Bouaziz, Andrew Pink, J.M. Carrascosa, Barbara Rewerska, Jacek C. Szepietowski, Dorota Krasowska, Blanka Havlíčková, Monika Kalowska, Nina Magnolo, Sylvia Pauser, Navid Nami, Maxwell Sauder, Vipul Jain, Kamila Padlewska, Soo Yeon Cheong, Patricia Fleuranceau Morel, Liliana Ulianov, Christophe Piketty - The Lancet 2024 cited by 125